RecruitingNot applicableNCT06873308
Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic Schistosomiasis
Studying Schistosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- IRCCS Sacro Cuore Don Calabria di Negrar
- Principal Investigator
- Federico Giovanni GobbiIRCCS Sacro Cuore Don Calabria
- Intervention
- UCP-LF CAA assay(device)
- Enrollment
- 278 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2024 – 2027
Study locations (8)
- Institute of Tropical Medicine (ITM), Antwerp, Belgium
- Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
- IRCCS Policlinico Sant'Orsola, Bologna, BO, Italy
- IRCCS Sacro Cuore Don Calabria, Negrar, VR, Italy
- AOU Careggi, Florence, Italy
- Medical Microbiology & Infectious Diseases, Erasmus MC, Rotterdam, Netherlands
- Tropical Medicine Unit of Hospital de Poniente, Almería, Spain
- Vall d'Hebron University Hospital, Barcelona, Spain
Collaborators
Leiden University Medical Center (LUMC)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06873308 on ClinicalTrials.govOther trials for Schistosomiasis
Additional recruiting or active studies for the same condition.